Aachen, Germany, 7 March 2022 – Grünenthal, a global science-driven pharmaceutical corporate, introduced that it has donated 400.000€ to the Crimson Move to beef up humanitarian aid efforts in Ukraine and Jap Europe. As well as, Grünenthal companions with Motion Medeor and the College Health center of RWTH Aachen to supply urgently wanted ache medicine to the area. The primary delivery with medication is ready to go away Aachen this week.
“We’re surprised and saddened through the assault on Ukraine. Our complete team spirit is with Ukraine’s other people and everybody affected, regardless of the place they arrive from. Grünenthal will give a contribution to making sure urgently wanted hospital treatment”, mentioned Gabriel Baertschi, CEO of Grünenthal.
About Grünenthal
Grünenthal is a world chief in ache control and comparable illnesses. As a science-based, privately-owned pharmaceutical corporate, we’ve got a protracted observe report of bringing leading edge therapies and state of the art applied sciences to sufferers international. Our goal is to switch lives for the simpler and innovation is our hobby. We’re focusing all of our actions and efforts on operating against our imaginative and prescient of an international freed from ache.
Grünenthal is headquartered in Aachen, Germany, and has associates in 29 nations throughout Europe, Latin The united states and the USA. Our merchandise are to be had in additional than 100 nations. In 2020 Grünenthal hired round 4,500 other people and accomplished gross sales of € 1.3 bn.
Additional information: www.grunenthal.com
Observe us on:
LinkedIn: Grunenthal Workforce
Instagram: grunenthal
For additional knowledge, please touch:
Fabia Kehren, Head Exterior Communications & Editorial Control
Tel.: +49 241 569-3269
Fabia.Kehren@grunenthal.com
Grünenthal GmbH, 52099 Aachen, Germany
